Doctors Group Sues FDA over ( Daxas, Daliresp) , Roflumilast for COPD


-Physicians for Integrity in Medical Research says in its federal complaint against Food and Drug Administration Commissioner Margaret Hamburg

– best-case scenario showed that roflumilast reduced the number of exacerbations by one episode a year for every five patients treated

– the regulator ignored the “statistically significant increase in incidents of prostate and lung cancer in patients taking roflumilast.”

———- Possible safe Option Vinpocetine

-Published today in the Proceedings of the National Academy of Sciences vinpocetine has great potential for the treatment of COPD and other inflammatory diseases.”

-has no evidence of toxicity or noticeable side effects in human patients



Enhanced by Zemanta

Categories: Corruption - Fabricated Data, Ineffective Treatments

Tags: , , , , , , ,

%d bloggers like this: